Nicotinic Acid in Hemodialysis Patients With Hyperphosphatemia

Phase 4 Unknown 45 enrolled Jiujiang No.1 People's Hospital

RandomizedCrossoverTriple-blindTreatment

Summary

With calcium carbonate as the positive control drug, to observe the effectiveness and safety of nicotinic acid in hemodialysis patients with hyperphosphatemia

Timeline

Start: 2016-07
Primary completion: 2016-09
Completion: 2016-09

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Calcium carbonate	Other / unclassified	500 mg	Oral
Subject	Niacin	Small molecule	100 mg	—

Nicotinic Acid in Hemodialysis Patients With Hyperphosphatemia

Summary

Timeline

Drugs

Indications